Peptides & Premium Additives Material A

1. INCI & CAS

INCI: Palmitoyl Tripeptide-1 · CAS: 147732-56-7

2. Role in the formula

Palmitoyl tripeptide-1 is a cosmetic lipopeptide. The guide uses a low ppm-to-0.05% framing and does not claim a clinical lift.

3. Typical use levels (formulation guide)

• Formulation guidance for serums and eye creams: about 2–10 ppm of pure peptide, or as the supplier blend states for the formula.

Follow the supplier blend TDS. Many trade blends are already diluted.

4. Regulatory sources & global compliance

• A CosIng listing for Palmitoyl Tripeptide-1 provides ingredient information, not approval of a supplied grade or finished product.
• Before EU placement, Regulation (EC) No 1223/2009 requires a product-level safety assessment for the complete formula that contains Palmitoyl Tripeptide-1 as a finished-product assessment.
• Verify the purchased Palmitoyl Tripeptide-1 grade using supplier data, alongside the applicable filing rules for the destination market.

5. Safety & risk assessment

This level is a cosmetic-formulation guide; it does not authorize a drug or OTC product and the finished formula still needs patch and stability testing.

6. Stability & packaging

Protect sealed bulk from warmth and direct light; consider an airless or pump format when oxidation sensitivity warrants it; test the selected package with the confirmed batch for stability and fit.

7. Claims language (Do / Don’t)

• The cosmetic concept for Palmitoyl Tripeptide-1 in this entry centers on peptide firming.

• This cosmetic guide does not support drug claims, cure claims, or a certification that is absent from the product records.
• The Palmitoyl Tripeptide-1 entry should not be cited in support of whitening, acne-treatment, antiperspirant, sun-protection, or hair-growth benefits.

1. INCI & CAS

INCI: Palmitoyl Tetrapeptide-7 · CAS: pending supplier / regulatory confirmation for the selected grade

2. Role in the formula

Used as a cosmetic peptide. Identity and assay follow the supplier blend, not a clinical claim. CAS left pending the exact salt form.

3. Typical use levels (formulation guide)

• For leave-on, use as the supplier blend states, typically well below 0.1% pure peptide.

Follow the blend TDS.

4. Regulatory sources & global compliance

• The CosIng record for Palmitoyl Tetrapeptide-7, where listed, is informational rather than product-specific authorization.
• For a cosmetic sold in the EU, Regulation (EC) No 1223/2009 requires a safety assessment covering the complete formulation with Palmitoyl Tetrapeptide-7 for the complete formula intended for sale.
• Check the supplier's technical information for the Palmitoyl Tetrapeptide-7 grade and confirm the relevant market filing list.

5. Safety & risk assessment

Read the recorded level as a cosmetic formulation guide; the listed level does not itself confer drug or OTC status and the finished formula still needs patch and stability testing.

6. Stability & packaging

Store sealed bulk away from heat and sunlight; take oxidation sensitivity into account when selecting the final pack; confirm final stability and pack compatibility on a representative batch.

7. Claims language (Do / Don’t)

• The formulation note describes Palmitoyl Tetrapeptide-7 as part of a cosmetic direction focused on second peptide.

• The development record is not evidence of drug effects, cures, or certification claims that go beyond the documented ingredient information.
• This cosmetic entry naming Palmitoyl Tetrapeptide-7 does not confirm whitening effects, acne treatment, antiperspirant performance, sunscreen protection, or hair growth.

1. INCI & CAS

INCI: Glycerin · CAS: 56-81-5

2. Role in the formula

The glycerin note covers its polyol-humectant role in washes, gels, and emulsions and gives a formulation guide level.

3. Typical use levels (formulation guide)

• 3–8% is listed for gels and serums in this reference.
• The guide range for creams is 2–5% in this reference.
• For rinse-off, the recorded level is 2–4% as a formulation guide.

Use the water phase to introduce Glycerin; no melting stage is required.

4. Regulatory sources & global compliance

• Treat any CosIng entry for Glycerin as a reference only; verify the grade and intended use under current market rules.
• For an EU-market product, Regulation (EC) No 1223/2009 requires the final cosmetic with Glycerin to undergo a safety assessment for the specific product as it will be marketed.
• Confirm the actual Glycerin grade from supplier documentation and check requirements where the product will be sold.

5. Safety & risk assessment

The concentration shown is guidance for cosmetic formulation; it should not be read as a drug authorization or OTC listing and patch and stability testing remain part of finished-product review.

6. Stability & packaging

Keep bulk supplies closed, cool, and protected from sunlight; where oxidation is a concern, evaluate airless or pump packaging; confirm stability and pack fit with the final formula.

7. Claims language (Do / Don’t)

• The formulation note describes Glycerin as part of a cosmetic direction focused on humectant function.

• The ingredient record does not demonstrate therapeutic results, cure claims, or unverified certification claims.
• The cosmetic guidance for Glycerin cannot establish skin whitening, acne care, sweat reduction, sun protection, or hair-growth outcomes.